2024

1. Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

   Haematologica

2. CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression

   Frontiers in Oncology, Vol. 14

3. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

   British Journal of Surgery, Vol. 111, Núm. 3

4. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

   Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723

5. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer

   International Journal of Molecular Sciences, Vol. 25, Núm. 4

6. ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression

   International Journal of Molecular Sciences, Vol. 25, Núm. 6

7. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

   Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

8. Functional proteomics based on protein microarray technology for biomedical research

   Advances in Protein Chemistry and Structural Biology (Academic Press Inc.), pp. 49-65

9. Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma

   Scientific Reports, Vol. 14, Núm. 1

10. Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients

    Blood cancer journal

11. LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma

    The British journal of dermatology, Vol. 190, Núm. 6, pp. 876-884

12. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

    Haematologica, Vol. 109, Núm. 1, pp. 115-128

13. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome

    Biology, Vol. 13, Núm. 5

14. Prevalence and Consequences of a Delayed Diagnosis in Multiple Myeloma: A Single Institution Experience

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 7, pp. 478-483

15. Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

    Haematologica, Vol. 109, Núm. 3, pp. 877-887

16. Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

    Leukemia

17. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

18. Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

    Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152

19. Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia

    American Journal of Hematology, Vol. 99, Núm. 4, pp. 586-595

20. Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide

    Nature Communications, Vol. 15, Núm. 1